About this trial
This is a pilot study to assess using validated outcome measures how ingesting pumpkin seed oil extract supports patient bladder function in a United States population.
Eligibility criteria
Qualifiers
All patients evaluated at Northwestern's IPHP who report bladder function consistent with overactive bladder (urinary urgency, with or without urinary frequency more than 8 times daily or nocturia, with or without urgency urinary incontinence) at their index visit, who are also willing to use a dietary supplement and not initiate additional behavioral, medication or procedural treatment for 12 weeks following pumpkin seed oil extract initiation.
Disqualifiers
Use of other supplements that contain pumpkin seed oil
≥Stage 3 pelvic organ prolapse
Urinary post-void residual ≥150cc
Culture-proven urinary tract infection at time of study enrollment
Trial design
Treatments tested in this trial
- Pumpkin Seed Extract